Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis
Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The MANUS Trial aims to examine the safety, feasibility and potential efficacy of
intramuscularly injected allogeneic mesenchymal stromal cells as treatment for digital ulcers
of systemic sclerosis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
UMC Utrecht
Collaborator:
ZonMw: The Netherlands Organisation for Health Research and Development